5.69
+0.1001(+1.79%)
Currency In USD
| Previous Close | 5.59 |
| Open | 5.57 |
| Day High | 5.77 |
| Day Low | 5.5 |
| 52-Week High | 12.4 |
| 52-Week Low | 3 |
| Volume | 34,777 |
| Average Volume | 62,461 |
| Market Cap | 38.34M |
| PE | -0.61 |
| EPS | -9.37 |
| Moving Average 50 Days | 5.47 |
| Moving Average 200 Days | 4.9 |
| Change | 0.1 |
If you invested $1000 in Generation Bio Co. (GBIO) since IPO date, it would be worth $23.05 as of December 31, 2025 at a share price of $5.69. Whereas If you bought $1000 worth of Generation Bio Co. (GBIO) shares 2 years ago, it would be worth $141.9 as of December 31, 2025 at a share price of $5.69.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
XOMA Royalty Enters into Agreement to Acquire Generation Bio
GlobeNewswire Inc.
Dec 15, 2025 10:00 PM GMT
- Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with Moderna - - Generation Bio’s cell-targeted lipid nanoparticles (ctLNP) delivery platform for small interfering RNA (siRNA) and
Generation Bio Announces Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Nov 05, 2025 9:05 PM GMT
CAMBRIDGE, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company, today reported third quarter financial results. Third Quarter 2025 Financial Results Cash Position: Cash, cash equivalents, and marketab
Generation Bio Announces CEO Transition
GlobeNewswire Inc.
Oct 22, 2025 8:05 PM GMT
• Geoff McDonough, MD to step down as CEO & President and become Chair of the Company’s Board of Directors • Current Chief Legal Officer Yalonda Howze, JD named Interim CEO & President CAMBRIDGE, MASS., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Generation